• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Benzylpiperidines 4-benzylpiperidines

Comprehensive Overview of 4-(3,4-Difluorophenyl)methylpiperidine (CAS No. 203860-03-1)

4-(3,4-Difluorophenyl)methylpiperidine (CAS No. 203860-03-1) is a fluorinated piperidine derivative that has garnered significant attention in pharmaceutical and chemical research due to its unique structural properties. This compound, characterized by the presence of a difluorophenyl group attached to a methylpiperidine backbone, serves as a critical intermediate in the synthesis of various bioactive molecules. Researchers are increasingly exploring its potential applications in drug discovery, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors.

The growing interest in fluorinated compounds like 4-(3,4-Difluorophenyl)methylpiperidine stems from their enhanced metabolic stability and bioavailability compared to non-fluorinated analogs. These properties make them ideal candidates for addressing challenges in medicinal chemistry, such as improving drug half-life and target specificity. Recent studies have highlighted the role of fluorine substitution in optimizing ligand-receptor interactions, a topic frequently searched by professionals in drug design and computational chemistry.

In the context of synthetic chemistry, 4-(3,4-Difluorophenyl)methylpiperidine is often utilized as a building block for constructing more complex molecular architectures. Its piperidine ring provides a rigid scaffold that can be functionalized to modulate pharmacological activity. This aligns with current trends in fragment-based drug discovery (FBDD), where small molecules like this are used to probe protein binding sites. Searches related to piperidine derivatives in FBDD have surged, reflecting the compound's relevance in modern research.

Another area of interest is the compound's potential role in neuropharmacology. The difluorophenyl moiety is structurally similar to motifs found in several FDA-approved drugs targeting neurotransmitter systems. This has led to speculation about its utility in developing novel antidepressants or antipsychotics, topics frequently queried in academic and industry forums. However, rigorous preclinical validation is required before any therapeutic claims can be substantiated.

From a material science perspective, the electron-withdrawing nature of the fluorine atoms in 4-(3,4-Difluorophenyl)methylpiperidine influences its physicochemical properties, such as solubility and lipophilicity. These attributes are crucial for formulators working on drug delivery systems, another hot topic in pharmaceutical searches. The compound's logP value and hydrogen bonding capacity are often analyzed to predict its behavior in biological systems.

Quality control of 4-(3,4-Difluorophenyl)methylpiperidine involves advanced analytical techniques like HPLC, NMR, and mass spectrometry, ensuring compliance with Good Manufacturing Practices (GMP). Purity standards are critical, as impurities may affect downstream applications—a concern frequently raised in pharmaceutical quality assurance discussions. The compound's CAS No. 203860-03-1 serves as a unique identifier for regulatory documentation and patent filings.

Environmental and safety assessments of fluorinated piperidines are also emerging as a research focus, coinciding with increased public interest in green chemistry. While 4-(3,4-Difluorophenyl)methylpiperidine itself isn't classified as hazardous, its synthetic byproducts require proper disposal—a subject often searched in conjunction with laboratory waste management protocols.

In summary, 4-(3,4-Difluorophenyl)methylpiperidine (CAS No. 203860-03-1) represents a versatile tool in contemporary chemical research. Its applications span drug discovery, material science, and analytical chemistry, making it a compound of enduring interest. As search trends indicate, scientists continue to explore its derivatives for innovative solutions in life sciences and beyond.

• 92822-02-1(4-(4-Fluorobenzyl)piperidine)
• 382637-47-0(3-(4-Fluorobenzyl)piperidine)
• 202126-85-0(4-[(3-fluorophenyl)methyl]piperidine)
• 37656-48-7(4-(4-Fluorophenyl)piperidine)
• 412310-88-4(4-(3,5-Difluorophenyl)piperidine)
• 104774-88-1(4-(3-Fluorophenyl)piperidine)
• 275815-80-0((3S)-3-[(4-fluorophenyl)methyl]piperidine)
• 795261-46-0(3-(3-Fluorophenyl)methylpiperidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)